Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
07/2000
07/05/2000CN1258739A Recombined adenovirus expressing human interleukin 18 and its preparation and use
07/05/2000CN1258738A Recombined adenovirus expressing the stimulating factor of human granulocyte-macrophage colony and its preparation and use
07/05/2000CN1258737A Recombined toxin adenovirus mutant for treating cancer gene HER-2/neu overexpressed tumor
07/04/2000US6084083 Amino acid sequence of polypeptide; for prognosis, diagnosis, monitoring, rational drug design, and/or therapeutic intervention of t helper cell related disorders including crohn's disease, lyme disease, insulin-dependent diabetes
07/04/2000US6083750 Adenovirus vectors
07/04/2000US6083684 Viral products
06/2000
06/29/2000WO2000037942A1 Conjugates for detecting viruses that cause diseases of the respiratory tract and use thereof
06/29/2000WO2000037487A1 αvβ6 INTEGRIN INHIBITORS
06/29/2000WO2000006717A3 Improved transformation efficiency in phage display through modification of a coat protein
06/29/2000WO2000001409A3 Porcine circovirus and parvovirus vaccine
06/29/2000CA2355874A1 .alpha.v.beta.6 integrin inhibitors
06/28/2000EP1013771A1 Non-nuclear chromosomal transformation
06/28/2000EP1013757A2 Attenuated forms of bovine viral diarrhea virus
06/28/2000EP1012338A1 A tumor suppressor designated ts10q23.3
06/28/2000EP1012321A2 Viral infection of cells using viral vectors
06/28/2000EP1012295A1 Alphavirus rna replicon systems
06/28/2000EP1012245A1 Surface expression system of hepatitis b virus surface antigen and core antigen of hepatitis c virus by using ice-nucleation protein
06/28/2000EP1012244A1 Rhabdoviruses with reengineered coats
06/28/2000CN1258317A Process for expression of genes of dengue viruses
06/27/2000US6080578 Cytopathic adenoviral E1B mutated viruses for therapy and prophylaxis of neoplasia
06/27/2000US6080571 Highly efficient production and isolation of viral particles utilizing tentacle anion exchange
06/27/2000US6080570 Method of producing a vaccine for Swine Infertility and Respiratory Syndrome
06/27/2000US6080569 Adenovirus vectors generated from helper viruses and helper-dependent vectors
06/27/2000US6080408 Particles contain mutations to reduce gag-dependent rna-packaging of the gag gene product, eliminate reverse transcriptase, integrase activity and rnase h activity of the pol gene product through genetic manipulation; vaccines; aids
06/27/2000CA2076744C Viral agent associated with mystery swine disease
06/22/2000WO2000036099A1 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase
06/22/2000WO2000036093A2 Intein-mediated cyclization of peptides
06/22/2000WO2000035481A2 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
06/22/2000WO2000035479A1 Synthetic virus-like particles with heterologous epitopes
06/22/2000WO2000035478A1 Treatment of papillomavirus infections
06/22/2000WO2000023955A8 Virus-like particles for the induction of autoantibodies
06/22/2000CA2440933A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
06/22/2000CA2355934A1 Intein mediated cyclization of peptides
06/22/2000CA2355270A1 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
06/22/2000CA2354444A1 Synthetic virus-like particles with heterologous epitopes
06/22/2000CA2353866A1 Treatment of papillomavirus infections
06/22/2000CA2290220A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
06/21/2000EP1010981A1 Conjugates to detect viruses and their use
06/21/2000EP1010759A1 Non-b non-c non-g hepatitis virus gene, polynucleotide, polypeptide, virion, method for separating virion, and method for detecting virus
06/21/2000EP1009809A2 Method for purifying and concentrating aav-2 and antigen portions thereof
06/21/2000EP1009808A2 Methods for generating high titer helper-free preparations of recombinant aav vectors
06/20/2000US6077940 Free solution ligand interaction molecular separation method
06/20/2000US6077700 Amino acid sequence; for study of cell cycle
06/20/2000US6077691 Infecting mammalian kidney cell with chimeric vaccina virus with synthetic promoter linked to sequence that encodes pres1-pres2-s hepatitis antigen, culturing and lysing the infected cell, harvesting antigen
06/20/2000US6077663 Composition for introducing nucleic acid complexes into higher eucaryotic cells
06/20/2000US6077659 Treating erythrocyte/photosensitizer composition with vitamin e, alpha-tocopherol phosphate, alpha-tocopherol succinate, or 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
06/20/2000US6077514 Characterized in that the viruses have a codon encoding an amino acid in the f protein chosen from specified amino acids at their amino acid numbers; temperature sensitive rsv phenotype; immunizing
06/20/2000US6077510 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
06/15/2000WO2000034529A1 Complete genome sequence of a simian immunodeficiency virus from a red-capped mangabey
06/15/2000WO2000034495A2 A method of genetically modifying very primitive quiescent human hematopoietic stem cells
06/15/2000WO2000034494A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
06/15/2000WO2000034446A1 Inactivation of non-enveloped viruses
06/15/2000WO2000034445A2 Live attenuated venezuelan equine encephalitis vaccine
06/15/2000WO2000034444A2 Method and composition for preserving viruses
06/15/2000WO2000011151A3 Direct oviduct transgenesis
06/15/2000WO1999061052A9 Oral immunization with papillomavirus virus-like particles
06/15/2000DE19823250C1 Continuous preparation of pathological viruses or recombinant proteins comprising infecting cells kept within a hollow sphere within a vessel while providing the cells with nutrients
06/15/2000CA2678259A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
06/15/2000CA2354374A1 Live attenuated venezuelan equine encephalitis vaccine
06/15/2000CA2351890A1 Method and composition for preserving viruses
06/14/2000EP1008652A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines
06/14/2000EP1007717A2 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
06/14/2000EP1007715A2 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
06/14/2000EP1007711A1 Für drosomycin kodierendes chimäres gen, dieses gen enhaltender vektor und herstellung von krankheitsresistenten transgenen pflanze
06/14/2000EP1007641A1 Adenoviruses having altered hexon proteins
06/14/2000EP1007640A1 New spumavirus isolated from humans
06/14/2000EP1007637A1 Methods for increasing the efficiency of recombinant aav product
06/14/2000EP1007552A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
06/14/2000CN1256695A Synthetic peptides useful in biological assays for detecting infections caused by group O HIV-1 viruses
06/14/2000CN1256310A Process for preparing fowl paralysis virus using continuous avian cell line
06/13/2000US6075122 A peptide for the detection, monitoring, and treatment of cancer in animals; anticarciongenic agents
06/09/2000CA2289951A1 Processes for preparation of marek's disease virus using continuous avian cell lines
06/08/2000WO2000032755A1 Stable, attenuated rabies virus mutants and live vaccines thereof
06/08/2000WO2000032754A1 An improved method for the production and purification of adenoviral vectors
06/08/2000WO2000032753A1 Heat inactivated retrovirus preparations
06/08/2000WO2000032625A1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
06/08/2000WO2000032227A2 Ordered molecular presentation of antigens, method of preparation and use
06/08/2000WO2000032226A2 Xenograft animal model for the induction of papillomas, the production of papillomavirus and the propagation thereof
06/08/2000WO2000032221A2 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000WO2000015820A8 Adenovirus vectors containing cell status-specific response elements and methods of use thereof
06/08/2000WO2000008191A3 Herpes virus vectors for dendritic cells
06/08/2000CA2851896A1 Plant diacylglycerol acyltransferases
06/08/2000CA2354183A1 Ordered molecular presentation of antigens, method of preparation and use
06/08/2000CA2352738A1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
06/08/2000CA2347835A1 Promotion or inhibition of angiogenesis and cardiovascularization
06/07/2000EP1006178A2 An immortal cell line derived from grouper Epinephelus coioides and its applications
06/07/2000EP1005561A1 Vector and viral vectors, and packaging cell lines for propagating same
06/07/2000EP1005535A1 Attenuation of negative stranded rna viruses by rearrangement of their genes and uses thereof
06/07/2000EP1005377A2 Receptor-mediated gene delivery using bacteriophage vectors
06/07/2000EP1005376A1 Methods and compositions for use in gene therapy for treatment of hemophilia
06/07/2000EP1005366A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof
06/07/2000EP1005363A2 Recombinant dimeric envelope vaccine against flaviviral infection
06/07/2000CN1255543A Process for increasing output of hallworm virus
06/06/2000US6071742 Coxsackie virus as a vector for delivery of anti-inflammatory cytokines
06/06/2000US6071736 Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus
06/06/2000US6071730 Cell ablation using trans-splicing ribozymes
06/06/2000US6071692 Inserting exogenous genes into cells; inserting gene into plasmid and transforming cell
06/06/2000US6071512 Administering replication defective recombinant retrovirion with gene operable linked to control sequence
06/02/2000WO2000031280A2 Use of plus-strand synthesis elements in retroviral vectors
06/02/2000WO2000031236A2 Vectors for gene mutagenesis and gene discovery by gene trapping